Detailed information for compound 1976765

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 421.472 | Formula: C21H19N5O3S
  • H donors: 1 H acceptors: 5 LogP: 1.61 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: N#CC1(CC1)NC(=O)Cc1nnc(o1)Cc1nc2c(s1)cc(cc2)C1=CCOCC1
  • InChi: 1S/C21H19N5O3S/c22-12-21(5-6-21)24-17(27)10-18-25-26-19(29-18)11-20-23-15-2-1-14(9-16(15)30-20)13-3-7-28-8-4-13/h1-3,9H,4-8,10-11H2,(H,24,27)
  • InChiKey: NWBCIHPRDVLWLS-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens lipase, endothelial Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis Tubulin beta 2C chain 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Echinococcus granulosus tubulin subunit beta 0.016 0.5 0.5
Entamoeba histolytica tubulin family protein 0.016 0.5 0.5
Plasmodium falciparum tubulin beta chain 0.016 0.5 0.5
Toxoplasma gondii beta-tubulin, putative 0.016 0.5 0.5
Loa Loa (eye worm) tubulin beta chain 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Loa Loa (eye worm) tubulin beta-4 chain 0.016 0.5 0.5
Echinococcus multilocularis beta tubulin 0.016 0.5 0.5
Trichomonas vaginalis tubulin gamma chain, putative 0.016 0.5 0.5
Loa Loa (eye worm) tubulin beta-2A chain 0.016 0.5 0.5
Echinococcus granulosus tubulin beta 1 chain 0.016 0.5 0.5
Echinococcus multilocularis Tubulin beta 2C chain 0.016 0.5 0.5
Loa Loa (eye worm) beta-tubulin 0.016 0.5 0.5
Echinococcus multilocularis Tubulin beta 2C chain 0.016 0.5 0.5
Schistosoma mansoni tubulin subunit beta 0.016 0.5 0.5
Echinococcus granulosus beta tubulin 0.016 0.5 0.5
Loa Loa (eye worm) BEN-1 protein 0.016 0.5 0.5
Echinococcus granulosus Tubulin beta 2C chain 0.016 0.5 0.5
Toxoplasma gondii beta-1 tubulin, putative 0.016 0.5 0.5
Echinococcus granulosus tubulin beta 4A class IVa 0.016 0.5 0.5
Trypanosoma brucei beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Entamoeba histolytica tubulin family protein 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Trichomonas vaginalis tubulin, putative 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Schistosoma mansoni tubulin subunit beta 0.016 0.5 0.5
Echinococcus granulosus Tubulin beta 2C chain 0.016 0.5 0.5
Schistosoma mansoni tubulin subunit beta 0.016 0.5 0.5
Trichomonas vaginalis tubulin epsilon chain, putative 0.016 0.5 0.5
Loa Loa (eye worm) BEN-1 protein 0.016 0.5 0.5
Echinococcus granulosus Tubulin beta 2C chain 0.016 0.5 0.5
Trypanosoma brucei beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Echinococcus multilocularis tubulin beta 1 chain 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Echinococcus multilocularis Tubulin beta 2C chain 0.016 0.5 0.5
Echinococcus multilocularis beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Loa Loa (eye worm) tubulin beta-1 chain 0.016 0.5 0.5
Trypanosoma cruzi beta tubulin, putative 0.016 0.5 0.5
Trypanosoma brucei beta tubulin 0.016 0.5 0.5
Brugia malayi beta-tubulin, identical 0.016 0.5 0.5
Trichomonas vaginalis tubulin epsilon chain, putative 0.016 0.5 0.5
Echinococcus granulosus Tubulin beta 2C chain 0.016 0.5 0.5
Trypanosoma brucei beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Schistosoma mansoni tubulin subunit beta 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Plasmodium vivax tubulin beta chain, putative 0.016 0.5 0.5
Toxoplasma gondii beta tubulin 0.016 0.5 0.5
Trichomonas vaginalis tubulin alpha chain, putative 0.016 0.5 0.5
Echinococcus granulosus beta tubulin 0.016 0.5 0.5
Trichomonas vaginalis tubulin beta chain, putative 0.016 0.5 0.5
Giardia lamblia Beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Giardia lamblia Beta tubulin 0.016 0.5 0.5
Echinococcus granulosus Tubulin beta 2C chain 0.016 0.5 0.5
Echinococcus multilocularis tubulin subunit beta 0.016 0.5 0.5
Echinococcus multilocularis tubulin, beta 4A class IVa 0.016 0.5 0.5
Schistosoma mansoni tubulin subunit beta 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Leishmania major beta tubulin 0.016 0.5 0.5
Echinococcus multilocularis Tubulin beta 2C chain 0.016 0.5 0.5
Giardia lamblia Beta tubulin 0.016 0.5 0.5
Schistosoma mansoni tubulin subunit beta 0.016 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 8 nM BindingDB_Patents: Inhibition Assay. After the present compound dissolved in DMSO was added to become 0.5% DMSO to the reaction buffer consisting of 20 mM tris hydrochloric acid (pH7.4), bovine serum albumin (0.5%), calcium chloride (4 mM), sodium chloride (150 mM) and human HDL (2 mg/ml), the EL enzyme was added (total volume was 20 µl). After 4-hour reaction at 37 C., non-esterified fatty acid (NEFA) generated from HDL by EL was measured with a commercially available assay kit and the amount of NEFA was used as an index of enzyme activity. Considering the enzyme activity without the inhibitor as a control value, the inhibition rate of each concentration of the present compound was calculated, and 50% inhibitory concentration (IC50 value) was calculated from an inhibition curve. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.